Chinese Journal of Dermatology ›› 2020, Vol. 53 ›› Issue (1): 40-44.doi: 10.35541/cjd.20190409

• Original Articles • Previous Articles     Next Articles

Effect of Beclin1 overexpression on biological behaviors of SK-MEL-2 human malignant melanoma cells

Xu Yanyan, Wang JiuJiang, Zhang Ling, Han Zhao, Niu Liang, Zhang Jianzhong, Liu Zhao, Li Gaijing, Li Xiaobing, Liu Qing, Liu Zhijun, Li Xiaojing   

  1. Department of Dermatology, Affiliated Hospital of Hebei University of Engineering, Handan 056002, Hebei, China
  • Received:2019-03-19 Revised:2019-11-17 Online:2020-01-15 Published:2019-12-31
  • Contact: Li Xiaojing; Wang Jiujiang E-mail:zlmdsh@126.com; 1137975423@qq.com

Abstract: 【Abstract】 Objective To evaluate the effect of overexpression of the autophagy marker gene Beclin1 on biological behaviors of SK-MEL-2 human malignant melanoma cells. Methods Western blot analysis was performed to determine the protein expression of Beclin1 in melanoma cell lines A375 and SK-MEL-2. SK-MEL-2 cells with low Beclin1 protein expression were selected as research objects, and divided into 3 groups: blank group receiving no treatment, negative control group transfected with pcDNA.3.1/myc-His (-) A, and experimental group transfected with pcDNA3.1-Beclin1 plasmid. After 2-week culture, cell counting kit-8 (CCK-8) assay was conducted to evaluate the effect of Beclin1 on cell proliferation at 24, 48 and 72 hours, and Transwell assay and wound-healing assay were performed to assess the effect of Beclin1 overexpression on the invasion and migration abilities of SK-MEL-2 cells. Repeated measures analysis of variance and completely randomized analysis of variance were used to analyze differences in indices among groups, and least significant difference (LSD)-t test was used for multiple comparisons. Results The protein expression of Beclin1 was significantly lower in the SK-MEL-2 cells (0.037 ± 0.010) than in the A375 cells (0.670 ± 0.150, F = 46.62, P<0.05). The experimental group showed significantly increased protein expression of Beclin1 (0.32 ± 0.04) compared with the negative control group (0.06 ± 0.02, P < 0.05) and blank group (0.07 ± 0.02, P < 0.05). CCK-8 assay revealed a significant difference in the cell proliferation rate among different groups and different time points (F = 1 077.36, 4 903.04 respectively, both P<0.05), and there was a significant interaction between the transfection treatment and time (F = 205.20, P<0.05). Transwell assay showed that the number of SK-MEL-2 cells crossing the chamber per high-power field (× 200) after 24-hour treatment was significantly lower in the experimental group (18.67 ± 1.19) than in the negative control group (87.89 ± 6.05, P<0.05) and blank group(86.78 ± 5.93, P<0.05). In the wound-healing assay, the cell migration distance was significantly shorter in the experimental group than in the blank group and negative control group at 24 and 48 hours (all P < 0.05). Conclusion Beclin1 overexpression can markedly inhibit the proliferation, invasion and migration of SK-MEL-2 cells.

Key words: Autophagy, Melanoma, experimental , Cell proliferation, Cell migration assays, Beclin1